Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Preferred Shares (2017)

Rocket Pharmaceuticals (RCKT) has disclosed Preferred Shares for 1 consecutive years, with $25.4 million as the latest value for Q4 2017.

  • Quarterly Preferred Shares changed N/A to $25.4 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $25.4 million through Dec 2017, changed N/A year-over-year, with the annual reading at $25.4 million for FY2017, N/A changed from the prior year.
  • Preferred Shares hit $25.4 million in Q4 2017 for Rocket Pharmaceuticals.
  • In the past five years, Preferred Shares ranged from a high of $25.4 million in Q4 2017 to a low of $25.4 million in Q4 2017.